Comparing biologic options for the management of Behcet’s disease-related uveitis-Reference-Cited by-同舟云学术

Comparing biologic options for the management of Behcet’s disease-related uveitis

Published:2023-02-15 Issue:3 Volume:19 Page:315-328
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Vitale Antonio¹^ORCID,Caggiano Valeria¹,Berlengiero Virginia¹,Perfetti Maria Orsetta²,Sota Jurgen¹^ORCID,Tosi Gian Marco²,Frediani Bruno¹^ORCID,Cantarini Luca¹^ORCID,Fabiani Claudia²^ORCID

Affiliation:

1. Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease, and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy

2. Ophthalmology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2023.2174103

Reference111 articles.

1. Behçet's syndrome: one year in review 2022

2. Uveitis in Behçet's Disease

3. Behçet's disease: general concepts and recent advances

4. Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study

5. Ocular features of Behcet's disease: An international collaborative study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value of Serum Asymmetric Dimethylarginine (ADMA) As a Novel Biomarker for Uveitis in Behçet’s Disease;Ocular Immunology and Inflammation;2024-04-16